(Q37044313)

17 August 2017

1 reference

title

Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease (English)

1 reference

17 August 2017

0 references

1 reference

cardiovascular disease

1 reference

1

Vera Regitz-Zagrosek

1 reference

17 August 2017

Elke Lehmkuhl

2

1 reference

17 August 2017

Shokufeh Mahmoodzadeh

series ordinal

3

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

4 Suppl B

1 reference

17 August 2017

page(s)

S162-77

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Comment on the provisional report from the WHO consultation

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Gender differences in the metabolic syndrome and their role for cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The metabolic syndrome: an emerging health epidemic in women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the "SYMFONIE" study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Central adiposity determines prevalence differences of the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Lipid metabolism in women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Climacteric modifications in body weight and fat tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Changes in energy balance and body composition at menopause: a controlled longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The emergence of the metabolic syndrome with menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Direct effects of sex steroid hormones on adipose tissues and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Sex differences in visceral fat lipolysis and metabolic complications of obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Leptin secretion from subcutaneous and visceral adipose tissue in women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Adiponectin as a biomarker of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Hysterectomy, Oophorectomy, and Endogenous Sex Hormone Levels in Older Women: The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Two Polymorphisms in the Peroxisome Proliferator-Activated Receptor- Gene Are Associated with Severe Overweight among Obese Women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Upregulation of myocardial estrogen receptors in human aortic stenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Cardiovascular mortality in overweight subjects: the key role of associated risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Influence of menopause on serum lipids and lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The importance of triglycerides: results from the Prospective Cardiovascular Münster (PROCAM) Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Assessing hypertension management in the community: trends of prevalence, detection, treatment and control of hypertension in the MONICA Project, Augsburg 1984–1995

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Should angiotensin II receptor blockers and statins be combined?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Renin angiotensin system and gender differences in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Gender differences in the regulation of blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Female sex hormones, salt, and blood pressure regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Impact of age and sex on plasma natriuretic peptide levels in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Obesity-associated hypertension: new insights into mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The Gly482Ser polymorphism in the peroxisome proliferator-activated receptor-gamma coactivator-1 gene is associated with hypertension in type 2 diabetic men.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with hypertension in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Incidence and epidemiology of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Gender differences in insulin-stimulated glucose utilization among African-Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Insulin resistance as the core defect in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Genomewide search for type 2 diabetes susceptibility genes in four American populations

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Diabetes as a risk factor for myocardial infarction: population and gender perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Sex differences in fasting glycemia as a risk factor for ischemic heart disease death

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Type II diabetes abrogates sex differences in endothelial function in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Metabolic implications of body fat distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Obesity and the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The role of gender in the progression of renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Risk associated with the metabolic syndrome versus the sum of its individual components

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

A simple linear model for the effect of changes in metabolic risk factors on coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980056-8

7 January 2021

10.1016/S1550-8579(07)80056-8

Identifiers

DOI

1 reference

17 August 2017

1 reference